Published

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2024-05-01
Source: PubMed
DOI: 10.1177/02698811241237870
PubMed: 38520045

Authors

Erritzoe D Barba T Spriggs MJ Rosas FE Nutt DJ Carhart-Harris R

Watch author

Derived topics and classifications

psilocybin Depression Receptor Pharmacology Wellbeing Clinical Trial Safety Drug Interactions Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12 Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”2026-06-30 A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder2026-05-01 The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21 Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.2024-05-01

Related papers

No close related records were found yet.